BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2018
View Archived Issues
Novel aCD40E vaccine demonstrates immunogenicity in vivo
Read More
Arcus Biosciences enrolling healthy volunteers in phase I study of AB-680
Read More
IP6 analogues explored as treatment for kidney stones
Read More
Positive topline results presented from phase III program evaluating FMX-103
Read More
New gene therapy acting on GABA-A receptor improves cognitive deficits related to schizophrenia
Read More
Can't we all just get along? Targeting innate immunity prevents transplant rejection
Read More
MicroRNA 31 levels predict response of patients with colon cancer to adjuvant cetuximab therapy
Read More
PLB-002, a SUMO mimetic polypeptide, shows inhibition of tau toxicity and motor/memory impairment
Read More
Kynurenine 3-monooxygenase promotes colorectal cancer tumorigenesis
Read More
PAI-1 antagonist TM5A15 demonstrates AD protection in vivo
Read More
BD-442618 reduces gambling-like behavior in rats
Read More
Preliminary results of phase I study of MK-1454/pembrolizumab for advanced solid tumors or lymphomas
Read More
Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases
Read More
DS-003 vaginal microbicide tablet achieves protective levels after administration to healthy women
Read More
Phase III results of the IL-17A antagonist ixekizumab for radiographic axial spondyloarthritis
Read More
Sunshine Lake Pharma initiates phase I trial of litapiprant
Read More
New phase I trial in China studies ZSP-1273 in healthy subjects
Read More
Potent antileukemia and antimyeloma activity by hedgehog pathway signaling inhibitor HH-78
Read More
Voyager Therapeutics reports longer-term data from phase Ib study of VY-AADC in Parkinson's disease
Read More
PledPharma initiates phase III program with PledOx
Read More
Immunomedics and AstraZeneca to study sacituzumab and durvalumab in metastatic NSCLC
Read More
Enrollment open in phase II study of Blautix for IBS
Read More
Visterra initiates first-in-human study with VIS-649 for IgA nephropathy
Read More
AstraZeneca initiates first-in-human study of AZD-9833 in advanced breast cancer
Read More
